PBSL Clarifies Mandate After Musa Tarawally’s Social Media Claims
The Pharmacy Board of Sierra Leone (PBSL), under the supervision of the Ministry of Health, has issued a public statement addressing a social media video by former government minister Alhaji Musa Tarawally, titled “Hon… Speaks Truth to Power.” In the video, Tarawally questions the regulation of medicines in Sierra Leone and accuses health authorities of negligence in controlling the inflow of dangerous drugs that are allegedly linked to the widespread abuse of “kush.”
The PBSL, in response, acknowledged the public interest the video has generated and welcomed the opportunity to clarify its regulatory role. It reaffirmed its mandate to ensure that all medicines and health products imported, distributed, and sold in Sierra Leone meet approved standards of quality, safety, and efficacy. The Board emphasized that it operates under the policy direction and oversight of the Ministry of Health, and its activities are guided by national and international pharmaceutical regulations.
Addressing the content of Tarawally’s video, the PBSL described his claims as “misinformed” and clarified that there is no verified evidence linking the substance known as kush to prescription medicines legally sold in registered pharmacies. The Board stressed that it maintains a robust inspection and pharmacovigilance system to monitor the importation and sale of medical products and ensure compliance with national laws.
In the statement, the PBSL also highlighted that the fight against kush and other illicit substances requires a collective national effort. It continues to collaborate with the National Public Health Agency, the Presidential Task Force on Kush, the Transnational Organized Crime Unit, and the National Drug Law Enforcement Agency to prevent and disrupt the circulation of illegal substances across the country.
The Board further clarified that it does not authorize the importation of oral Tramadol products exceeding 120 mg of active ingredient. It announced plans to review national pain management protocols in collaboration with the Pharmaceutical Society of Sierra Leone, the Medical and Dental Council, and other professional bodies to promote safer and evidence-based alternatives.
Meanwhile, the drug situation in Sierra Leone remains a growing national concern. The increasing abuse of kush, Tramadol, and other narcotic substances continues to devastate young people, families, and communities. Health professionals have warned that the crisis not only poses serious public health challenges but also threatens social stability. Experts say the fight against drug abuse must be intensified through strong law enforcement, community education, and improved rehabilitation services for users.
The PBSL concluded by reaffirming its commitment to ensuring that all medicines in Sierra Leone are safe, effective, and properly regulated. It also called on the public to rely on verified information from official health authorities rather than unverified social media claims.
